Evidence map›Paper›PMID 41427726›Full record

ArticleSexually transmitted diseases2026

Evaluation of Alinity m Sexually Transmitted Infection Assay for Simultaneous Detection of Chlamydia trachomatis , Neisseria gonorrhoeae , Trichomonas vaginalis , and Mycoplasma genitalium in Male Urine Specimens.

Richard Cullum, Luciana Girotto Gentil, Yan Zhang, Danijela Lucic, Barbara Van Der Pol

Abstract readEvaluation Study
In one paragraph

Article in Sexually transmitted diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Richard CullumFrom the Molecular Diagnostics at Abbott, Des Plaines, IL.
Luciana Girotto GentilAbbott Laboratories de Chile Ltda., Santiago, Chile.ORCID 0000-0002-1530-6809
Yan ZhangFrom the Molecular Diagnostics at Abbott, Des Plaines, IL.ORCID 0009-0003-9331-4868
Danijela LucicFrom the Molecular Diagnostics at Abbott, Des Plaines, IL.
Barbara Van Der PolUniversity of Alabama at Birmingham Heersink School of Medicine and UAB School of Public Health, Birmingham, AL.ORCID 0000-0003-3064-8564

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study evaluated the performance of the Alinity m sexually transmitted infection (STI) assay that can simultaneously detect Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and Mycoplasma genitalium (MG) in comparison with other commonly used Food and Drug Administration-cleared assays and laboratory-developed tests in male urine specimens.

methodsUrine specimens were collected from symptomatic and asymptomatic men across the United States. The Alinity m STI results were compared with the Composite Comparator Algorithm results established for each analyte.

resultsThe prevalence of single infections ranged from 1.8% for NG and TV to 6.1% for CT, with 2.6% of individuals coinfected with at least 2 STI pathogens. The overall positive agreement was ≥97.5% for all 4 analytes, with MG showing the lowest agreement. The κ score ranged from 0.82 to 0.98 across all analytes.

conclusionsThe Alinity m STI assay showed excellent concordance with the comparator assays demonstrated by the strong κ scores in male urine specimens.

Indexed as

Chlamydia InfectionsChlamydia trachomatisGonorrheaMycoplasma genitaliumMycoplasma InfectionsNeisseria gonorrhoeaeSexually Transmitted DiseasesTrichomonas vaginalisAdultCoinfectionHumansMaleSensitivity and SpecificityTrichomonas InfectionsUnited StatesUrine

Identifiers

PMID41427726
PMCPMC13007912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.